» Articles » PMID: 32594465

Oral Appliances in the Treatment of Oromandibular Dystonia: a Systematic Review

Overview
Publisher Springer
Specialty Neurology
Date 2020 Jun 29
PMID 32594465
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Oromandibular dystonia (OMD) is a clinically and etiologically heterogeneous form of focal dystonia with variable social and functional implications. The results of pharmacological treatment and botulinum toxin infiltrations are often unsatisfactory. We performed a systematic review on the effects of oral and dental appliances in patients with OMD. Most of the reports in the literature are single subject descriptions or small case series with a considerable variability in the type of dystonia, the type of evaluated appliances and in the outcome measures. Only one report included a large group of unselected patients that were evaluated with a mixture of outcome measures. Although it appears that a number of OMD patients, especially those who benefit from sensory tricks, may sustain some improvement with the use of oral appliances, no definitive conclusions can be drawn about the type of patients that may benefit, nor about the preferred type or mode of appliance. More research in this field is needed, using standardized approaches and clearly defined outcome measures in larger cohorts of OMD patients that are clinically and diagnostically well characterized.

Citing Articles

Neurophysiological Basis of Deep Brain Stimulation and Botulinum Neurotoxin Injection for Treating Oromandibular Dystonia.

Maezawa H, Hirata M, Yoshida K Toxins (Basel). 2022; 14(11).

PMID: 36356002 PMC: 9694803. DOI: 10.3390/toxins14110751.


Botulinum Toxin, a Drug with Potential Interest for Dentists-An Introduction.

Bakke M Toxins (Basel). 2022; 14(10).

PMID: 36287936 PMC: 9607019. DOI: 10.3390/toxins14100667.


Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale.

Yoshida K Toxins (Basel). 2022; 14(10).

PMID: 36287925 PMC: 9609031. DOI: 10.3390/toxins14100656.


Movement disorders of the mouth: a review of the common phenomenologies.

Ghadery C, Kalia L, Connolly B J Neurol. 2022; 269(11):5812-5830.

PMID: 35904592 DOI: 10.1007/s00415-022-11299-1.


Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.

Yoshida K Toxins (Basel). 2022; 14(4).

PMID: 35448891 PMC: 9026473. DOI: 10.3390/toxins14040282.


References
1.
Colosimo C, Suppa A, Fabbrini G, Bologna M, Berardelli A . Craniocervical dystonia: clinical and pathophysiological features. Eur J Neurol. 2010; 17 Suppl 1:15-21. DOI: 10.1111/j.1468-1331.2010.03045.x. View

2.
Fabbrini G, Defazio G, Colosimo C, Thompson P, Berardelli A . Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatment. Nat Clin Pract Neurol. 2009; 5(2):93-105. DOI: 10.1038/ncpneuro1006. View

3.
Lo S, Rosengart A, Novakovic R, Kang U, Shah D, Khan M . Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients. Neurocrit Care. 2005; 3(2):139-45. DOI: 10.1385/NCC:3:2:139. View

4.
Tan E, Jankovic J . Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry. 2000; 68(2):186-90. PMC: 1736782. DOI: 10.1136/jnnp.68.2.186. View

5.
Fasano A, Tinazzi M . Functional facial and tongue movement disorders. Handb Clin Neurol. 2016; 139:353-365. DOI: 10.1016/B978-0-12-801772-2.00031-X. View